The specific APE1 redox inhibitor E3330 is reported to cause tumor growth inhibition in cell lines and pancreatic cancer xenograft model in mice, demonstrating the potential of APE1 inhibitors in pancreatic cancer treatment [30]. The gene discussed is APEX1; the disease is neoplasm.